Hypercalcemia is a common finding in patients with multiple myeloma. Clinical manifestations of hypercalcemia correlate with the level of serum calcium. Ionized serum calcium (Ca (I)) will be increased in true hypercalcemia. In pseudohypercalcemia the Ionized Ca is normal, although binding of calcium to abnormal immunoglobulin causes increased serum calcium level. In the asymptomatic multiple myeloma patients with moderate to severe hypercalcemia, measurement of ionized calcium is critical to exclude pseudohypercalcemia. Here, we describe an asymptomatic 44-year-old man with multiple myeloma who had severe hypercalcemia, but normal serum Ionized Ca level.
INTRODUCTION
Hypercalcemia is a common biochemical disorder in clinical practice, which can be associated with a variety of clinical manifestation ranging from asymptomatic to life threatening conditions such as renal failure and coma. Generally, severity of clinical manifestation correlates with degree and chronicity of hypercalcemia 1 . Malignancy and primary hyperparathyroidism are the most common causes of hypercalcemia, accounting about 90% of cases. Multiple myeloma is one of the most common malignancies associated with hypercalcemia. Approximately 28% of myeloma patients have elevated serum calcium at the time of diagnosis 2 .
CASE PRESENTATION
A 44 -year-old man admitted to hospital because of sever hypercalcemia. He has had a history of progressive fatigue and generalized bone pain from three months ago. Other clinical signs and symptoms of clinical hypercalcemia such as renal, gastrointestinal, neurologic and cardiovascular manifestations were absent. He had no history of medical disease and was taking no medications except of analgesics for bone pain. Laboratory data showed serum calcium (Ca) 17.9 mg/dL, albumin 3.9 g/dL, phosphorous (P) 2. 
DISCUSSION
In severe hypercalemia marked symptoms such as polyuria, polydipsia, nausea, dehydration and changes in consciousness are present 2, 3 . Absence of associated symptoms in our patient indicates that ionized fraction is not increased. Several conditions are associated with pseudohypercalcemia, including prolonged use of tourniquet in sampling, dehydration, hyponatremia, excessive serum albumin, abnormally elevated calcium-binding globulin in hyper gammaglobulinemia and thrombocytosis 4-7. Paraproteinemia can interfere with many biochemical laboratory measurement including glucose 8 , bilirubin 9, 10 , sodium 11, 12 , chloride 11 , calcium 13 15 . In our patient, the persistent hypercalcemia and the subsequent elevated PTH level have led to the misdiagnosis of primary hyperparathyroidism concurrent with multiple myeloma. But, it seems that the increased PTH level was secondary to decreased ionized calcium level. Treatment of hypercalcemia and concomitant Vit D deficiency were the major causes of decreased ionized calcium. Normalization of PTH level after calcium and vitamin D supplementation indicates that our hypothesis regarding this patient laboratory abnormality is correct.
CONCLUSION
In multiple myeloma patients with severe hypercalcemia, especially when signs and symptoms of hypercalcemia are absent, clinicians should recognize pseudohypercalcemia as an unusual cause to avoid unnecessary therapies. Measurement of ionized serum calcium is helpful in these situations
